Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Using a Liquid Biopsy to Monitor Metastatic Breast Cancer Treatment

NCT05804578 is registered in ClinicalTrials.gov with Dr. Christopher Mueller as lead sponsor.

NCT NCT05804578
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05804578 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Using a Liquid Biopsy to Monitor Metastatic Breast Cancer Treatment
Lead sponsor
Dr. Christopher Mueller
Phase
Observational
Overall status
Recruiting
Start date
October 19, 2023
Completion date
April 30, 2026
Enrollment
150 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer